Rick Shinto and Penelope Kokkinides of InnovaCare

Rick Shinto

Rick Shinto is the President and Chief Executive Officer of the company Innova Care, and before he started working there, he was at Aveta Inc. where he served until its sale in 2012. He worked there from 2008.

He had served as a member of the management team there. Right now, he works as the CEO of InnovaCare’s health plans in Puerto Rico.

Experience

Shinto has had 20 years in this job, and he has excelled in most of what he has done. His area of specialization is clinical and operational healthcare experience. Before he started his job Aveta in 2008, he had been the Chief Medical Officer at NAMM California.

If you track back a little before that, he was the Chief Operating Officer of Medical Pathways Management Company. As you can see, from his previous positions, he has been exposed t the job, and he knows what he does.

Alma Mater

Shinto Got his Bachelor of Science from the University of California and his medical degree; he got from the State University of New York at Stony Brook and his MBA he got from the University of Redlands.

He has authored several pieces of healthcare articles and clinical medicine.

Penelope Kokkinides

She is the Chief Administrative Officer at InnovaCare and currently holds that position working with Dr. Rick Shinto. She had served as the Chief Operating Officer and then left but came back in 2015 to be the Chief Administrative Officer. She had also been the Vice President of Clinical Operations. View her infographic resume at Vizualize.me

Experience

  1. Penelope Kokkinides has had a career spanning over 20 years in the medical business. Most of these have been specialized in government healthcare like Medicaid and Medicare. She has also been in the managed care sectors.

Her Skills Include:

  • She is an expert when it comes to the management and administrative duties.
  • She can manage health care processes well.
  • She has knowledge of operations and running them.
  • She has skills for improvement and efficiencies in organizational structures.

Former Jobs

She worked at:

  • Centerlight Healthcare where she in charge of overall management.
  • Chief operating officer at Touchstone health.
  • Corporate vice president for Care Management and Disease Management at AmeriChoice

At AmeriChoice, she developed and implemented a model for the company’s running.

Alma Mater

She has:

  • A bachelor’s degree in Biological Sciences and Classical Languages from Binghamton University
  • Masters degree in Social Work from New York University
  • Advanced Degree in Alcohol and substance abuse
  • Masters Degree in Public health from Columbia University

Visit Bloomberg.com for more info on Penelope Kokkinides.

In Conclusion: They are both impressive in their jobs and experience.

Breakthrough Treatment for Multiple Sclerosis Discovered

Multiple Sclerosis is a disease that has the body’s immunity system attacking, and disabling the central nervous system (CNS). A clinical trial study named on the disease dubbed, HALT-MS, revealed that a high dosage of drugs that suppress the strength of the immunity system, coupled with a blood stem transplant, increase the chances of the sustained remission.

The NIAID, which is connected to the National Institute of Health sponsored the trial. It was coordinated by ITN which is funded by NIAID.

The trail study noted that sixty-nine percent of the people that participated in the pilot study did not experience progressive disability, new brain lesions or even relapse of the MS symptoms, five years after receiving the treatment.

The treatment is known as HDIT/HCT i.e. therapy that inhibits the activity in the immune system, and autologous cell transplanting in large doses. The study also observed that after going through the HDIT/HCT treatment, the participants did not need to continue taking any medication.

The trial treatment is centered on reducing the activity of the disease and eliminating the possibility of the CNS being disabled by this activity. This was done by the removal of the disease-inducing cells and rebooting the immune system by transplanting a participant’s blood-making stem cells.

The study has made tremendous success in stabilizing MS to date and reveal that HDIT/HCT can become a potential solution to people with relapsing-remitting multiple sclerosis.

Shiva Gopal Vasishta

Dr. Shiva Gopal Vasishta is well known for his specialty and contributions in Neurology globally. Dr. Gopal is also licensed to practice Psychiatry in Voorhees, New Jersey. He attained his medical degree from Government Medical College in 1979.

Dr. Shiva Gopal Vasishta went through his residency at Boston City Hospital and has over 40 years of medical excellence to date.

He currently operates his practice at Eastern Neurodiagnostic Associate. Dr. Shiva Gopal Vasishta is recognized for his affiliations with Kennedy Health System Cherry Hill where he is making significant contributions to the neurological field.